Tuesday Mar 4
Recent Study: ImmunoGen, Inc. - Product Pipeline Review - 2014
The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
ImmunoGen, Inc. Announces Webcast Of Presentations At Upcoming Investor Conferences
ImmunoGen, Inc. , a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast: a Cowen and Company 34th Annual Health Care Conference 9:20 am ET, March 4 in Boston, MA Help ... (more)
Press release distribution, EDGAR filing, XBRL, regulatory filings
He is a construction and business law and litigation specialist, and co-chair o... )--Genesis Energy, L.P. today announced that it has filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2013 with the Securities and Excha... )--Today, United Against Nuclear Iran resumed its Trade Delegation Campaign with a new focus on ... (more)
Immunogen VP Unloads $120,340 in Stock
Immunogen VP Charles Q. Morris unloaded 6,936 shares of Immunogen stock in a transaction that occurred on Wednesday, February 26th.
Insider Selling: Immunogen CEO Sells 15,000 Shares of Stock
Immunogen CEO Daniel M. Junius unloaded 15,000 shares of Immunogen stock in a transaction dated Tuesday, February 18th.
ImmunoGen, Inc. Appoints Ellie Harrison as Chief Human Resources Officer
Ms. Harrison brings to ImmunoGen more than thirty years of senior level Human Resources experience.
ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2014 Financial...
ImmunoGen also provided an update on Company and partner product programs . "We expect 2014 to be a very active year," commented , President and CEO.